

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to interleukin-15 (GO:0071350) | 6.14170605 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.96502868 |
| 3 | pyrimidine nucleoside catabolic process (GO:0046135) | 5.87991218 |
| 4 | negative regulation by host of viral transcription (GO:0043922) | 5.70723772 |
| 5 | eosinophil chemotaxis (GO:0048245) | 5.47184256 |
| 6 | positive regulation of interleukin-8 secretion (GO:2000484) | 5.26320332 |
| 7 | response to interleukin-15 (GO:0070672) | 5.20896037 |
| 8 | negative regulation of viral genome replication (GO:0045071) | 5.01462766 |
| 9 | eosinophil migration (GO:0072677) | 4.92489584 |
| 10 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.89166145 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.84040773 |
| 12 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.80280355 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 4.78312271 |
| 14 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.78000318 |
| 15 | positive regulation of defense response to virus by host (GO:0002230) | 4.76545523 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.70082514 |
| 17 | T cell migration (GO:0072678) | 4.67464518 |
| 18 | negative T cell selection (GO:0043383) | 4.61334965 |
| 19 | negative regulation of T cell apoptotic process (GO:0070233) | 4.57700407 |
| 20 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 4.50514838 |
| 21 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.48678410 |
| 22 | regulation of regulatory T cell differentiation (GO:0045589) | 4.47079790 |
| 23 | positive T cell selection (GO:0043368) | 4.39739647 |
| 24 | DNA demethylation (GO:0080111) | 4.30906007 |
| 25 | regulation of B cell differentiation (GO:0045577) | 4.30555573 |
| 26 | lymphocyte chemotaxis (GO:0048247) | 4.25005575 |
| 27 | positive regulation of interleukin-1 secretion (GO:0050716) | 4.24867771 |
| 28 | regulation of interleukin-1 beta secretion (GO:0050706) | 4.23685200 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 4.21523074 |
| 30 | negative regulation of viral transcription (GO:0032897) | 4.12854140 |
| 31 | cytolysis (GO:0019835) | 4.09747543 |
| 32 | macrophage chemotaxis (GO:0048246) | 4.06804164 |
| 33 | positive regulation of lymphocyte migration (GO:2000403) | 4.02385739 |
| 34 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.01948225 |
| 35 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.81766962 |
| 36 | regulation of interleukin-1 secretion (GO:0050704) | 3.79910224 |
| 37 | negative regulation of viral process (GO:0048525) | 3.77972954 |
| 38 | regulation of interleukin-8 secretion (GO:2000482) | 3.72048772 |
| 39 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.71330146 |
| 40 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.71330146 |
| 41 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.64567946 |
| 42 | negative thymic T cell selection (GO:0045060) | 3.59709714 |
| 43 | positive regulation of interleukin-1 beta production (GO:0032731) | 3.59236308 |
| 44 | cellular defense response (GO:0006968) | 3.58545270 |
| 45 | positive thymic T cell selection (GO:0045059) | 3.57695143 |
| 46 | lymph node development (GO:0048535) | 3.57320875 |
| 47 | negative regulation of cell killing (GO:0031342) | 3.56080157 |
| 48 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.56080157 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.55412518 |
| 50 | positive regulation of tolerance induction (GO:0002645) | 3.53858972 |
| 51 | regulation of T cell tolerance induction (GO:0002664) | 3.53129466 |
| 52 | thymic T cell selection (GO:0045061) | 3.51788713 |
| 53 | regulation of viral genome replication (GO:0045069) | 3.50410081 |
| 54 | membrane raft organization (GO:0031579) | 3.50136645 |
| 55 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.49657244 |
| 56 | T cell selection (GO:0045058) | 3.48132259 |
| 57 | activated T cell proliferation (GO:0050798) | 3.46556146 |
| 58 | regulation of calcium-mediated signaling (GO:0050848) | 3.46218489 |
| 59 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.39674407 |
| 60 | immunoglobulin mediated immune response (GO:0016064) | 3.38809425 |
| 61 | pyrimidine-containing compound catabolic process (GO:0072529) | 3.38095668 |
| 62 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.36238911 |
| 63 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.34797988 |
| 64 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.34707861 |
| 65 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.32436101 |
| 66 | DNA dealkylation (GO:0035510) | 3.31214096 |
| 67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.28172347 |
| 68 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.23805041 |
| 69 | positive regulation of cell killing (GO:0031343) | 3.22532701 |
| 70 | modulation by host of symbiont transcription (GO:0052472) | 3.21442987 |
| 71 | modulation by host of viral transcription (GO:0043921) | 3.21442987 |
| 72 | granulocyte activation (GO:0036230) | 3.20108277 |
| 73 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.18537862 |
| 74 | positive regulation of interleukin-1 production (GO:0032732) | 3.17229227 |
| 75 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 3.16407272 |
| 76 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.16028823 |
| 77 | positive regulation of humoral immune response (GO:0002922) | 3.15276093 |
| 78 | negative regulation of bone mineralization (GO:0030502) | 3.13641055 |
| 79 | regulation of lymphocyte migration (GO:2000401) | 3.13403362 |
| 80 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.12024055 |
| 81 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.11810267 |
| 82 | T cell costimulation (GO:0031295) | 3.11289718 |
| 83 | lymphocyte costimulation (GO:0031294) | 3.07225264 |
| 84 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 3.05747695 |
| 85 | positive regulation of macrophage differentiation (GO:0045651) | 3.05692709 |
| 86 | lymphocyte migration (GO:0072676) | 3.05584062 |
| 87 | response to interferon-beta (GO:0035456) | 3.04947616 |
| 88 | T cell receptor signaling pathway (GO:0050852) | 3.02692113 |
| 89 | leukocyte degranulation (GO:0043299) | 3.01029784 |
| 90 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.00776620 |
| 91 | actin nucleation (GO:0045010) | 2.95862818 |
| 92 | regulation of defense response to virus by host (GO:0050691) | 2.94785174 |
| 93 | regulation of T cell apoptotic process (GO:0070232) | 2.93380533 |
| 94 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.92851097 |
| 95 | cytidine metabolic process (GO:0046087) | 13.8254336 |
| 96 | cytidine catabolic process (GO:0006216) | 13.8254336 |
| 97 | cytidine deamination (GO:0009972) | 13.8254336 |
| 98 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 12.5158082 |
| 99 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 10.5263479 |
| 100 | DNA deamination (GO:0045006) | 10.4736628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.38071487 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.21968162 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.63522452 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.99255592 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.52862820 |
| 6 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.47400241 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.28674767 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.06143904 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.89492724 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.72009852 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.64142743 |
| 12 | MYB_26560356_Chip-Seq_TH1_Human | 2.38980601 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.33439699 |
| 14 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.23709461 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20692609 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.19976651 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.18140222 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.10355971 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.06443480 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.05159533 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 12.6507048 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 1.97802837 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 1.90313296 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 1.84226835 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.82094801 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80176870 |
| 27 | GATA3_26560356_Chip-Seq_TH2_Human | 1.74413917 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67814433 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.62494963 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61074912 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.52289784 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49723653 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48453478 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.45685670 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42031261 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41893200 |
| 37 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.41854726 |
| 38 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.40341477 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37222110 |
| 40 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.36540169 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34725089 |
| 42 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33059859 |
| 43 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.26899093 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25264954 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24226183 |
| 46 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13364885 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12776147 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12157407 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.11351380 |
| 50 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05653662 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04610475 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04385566 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.03692018 |
| 54 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02931978 |
| 55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.00094705 |
| 56 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98975841 |
| 57 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98771577 |
| 58 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97573964 |
| 59 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.94139055 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.93469590 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90872347 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89491986 |
| 63 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88982319 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87244136 |
| 65 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.84483621 |
| 66 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.82882917 |
| 67 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81084300 |
| 68 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.80767558 |
| 69 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79486155 |
| 70 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.78859768 |
| 71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78752938 |
| 72 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.78187672 |
| 73 | P300_27268052_Chip-Seq_Bcells_Human | 0.77254487 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75283650 |
| 75 | GATA3_26560356_Chip-Seq_TH1_Human | 0.73248005 |
| 76 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.72370475 |
| 77 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.72370475 |
| 78 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71783209 |
| 79 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.71647808 |
| 80 | VDR_22108803_ChIP-Seq_LS180_Human | 0.70690221 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70595742 |
| 82 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.70292516 |
| 83 | SA1_27219007_Chip-Seq_Bcells_Human | 0.66642273 |
| 84 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.65741123 |
| 85 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.65393317 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.65243663 |
| 87 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.64791616 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.64658966 |
| 89 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.62260204 |
| 90 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.61785240 |
| 91 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.61745934 |
| 92 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.61586451 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.61058506 |
| 94 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.60551356 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.59713309 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.59641621 |
| 97 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.59525753 |
| 98 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.57629697 |
| 99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.56865779 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.56436126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.50657879 |
| 2 | MP0009333_abnormal_splenocyte_physiolog | 4.95472658 |
| 3 | MP0003763_abnormal_thymus_physiology | 4.56356705 |
| 4 | MP0006082_CNS_inflammation | 4.18587425 |
| 5 | MP0009785_altered_susceptibility_to | 4.04245536 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.31482125 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.18751681 |
| 8 | MP0001800_abnormal_humoral_immune | 3.13627894 |
| 9 | MP0003436_decreased_susceptibility_to | 3.10393949 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.97528882 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.95624817 |
| 12 | MP0005387_immune_system_phenotype | 2.87608947 |
| 13 | MP0001790_abnormal_immune_system | 2.87608947 |
| 14 | MP0001819_abnormal_immune_cell | 2.85041602 |
| 15 | MP0005025_abnormal_response_to | 2.84305180 |
| 16 | MP0002723_abnormal_immune_serum | 2.82361207 |
| 17 | MP0003448_altered_tumor_morphology | 2.50532726 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.37121135 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.33195869 |
| 20 | MP0002419_abnormal_innate_immunity | 2.31257827 |
| 21 | MP0002398_abnormal_bone_marrow | 2.28713368 |
| 22 | MP0003866_abnormal_defecation | 2.27824773 |
| 23 | MP0000716_abnormal_immune_system | 2.27524886 |
| 24 | MP0000703_abnormal_thymus_morphology | 2.25469409 |
| 25 | MP0002166_altered_tumor_susceptibility | 2.13186446 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.09181357 |
| 27 | MP0000685_abnormal_immune_system | 1.91763981 |
| 28 | MP0002722_abnormal_immune_system | 1.88632499 |
| 29 | MP0003045_fibrosis | 1.84734558 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.82297642 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.81319948 |
| 32 | MP0002429_abnormal_blood_cell | 1.79821077 |
| 33 | MP0002405_respiratory_system_inflammati | 1.71604496 |
| 34 | MP0004947_skin_inflammation | 1.67057619 |
| 35 | MP0002006_tumorigenesis | 1.60835421 |
| 36 | MP0009763_increased_sensitivity_to | 1.60631471 |
| 37 | MP0003279_aneurysm | 1.60323605 |
| 38 | MP0009765_abnormal_xenobiotic_induced | 1.49940299 |
| 39 | MP0001958_emphysema | 1.49899209 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.49708818 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.40796913 |
| 42 | MP0008469_abnormal_protein_level | 1.40690489 |
| 43 | MP0003724_increased_susceptibility_to | 1.40516947 |
| 44 | MP0000858_altered_metastatic_potential | 1.36847002 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.35334328 |
| 46 | MP0002277_abnormal_respiratory_mucosa | 1.32193386 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.26953715 |
| 48 | MP0003075_altered_response_to | 1.18187930 |
| 49 | MP0001873_stomach_inflammation | 1.16847613 |
| 50 | MP0003786_premature_aging | 1.14245362 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.10619371 |
| 52 | MP0002163_abnormal_gland_morphology | 1.08232466 |
| 53 | MP0005310_abnormal_salivary_gland | 1.03376020 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.01475651 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.00889183 |
| 56 | MP0002933_joint_inflammation | 0.99408609 |
| 57 | MP0008873_increased_physiological_sensi | 0.98903618 |
| 58 | MP0009764_decreased_sensitivity_to | 0.94874427 |
| 59 | MP0002132_abnormal_respiratory_system | 0.93925592 |
| 60 | MP0000604_amyloidosis | 0.91392357 |
| 61 | MP0003183_abnormal_peptide_metabolism | 0.90678991 |
| 62 | MP0006054_spinal_hemorrhage | 0.89286232 |
| 63 | MP0001919_abnormal_reproductive_system | 0.89279358 |
| 64 | MP0001853_heart_inflammation | 0.88422834 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 0.87246731 |
| 66 | MP0002019_abnormal_tumor_incidence | 0.85922224 |
| 67 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85679115 |
| 68 | MP0000639_abnormal_adrenal_gland | 0.82851265 |
| 69 | MP0005165_increased_susceptibility_to | 0.81327515 |
| 70 | MP0005408_hypopigmentation | 0.76996826 |
| 71 | MP0004381_abnormal_hair_follicle | 0.75300231 |
| 72 | MP0005623_abnormal_meninges_morphology | 0.74329404 |
| 73 | MP0008260_abnormal_autophagy | 0.70466503 |
| 74 | MP0005390_skeleton_phenotype | 0.69743394 |
| 75 | MP0004510_myositis | 0.66259398 |
| 76 | MP0001348_abnormal_lacrimal_gland | 0.65855053 |
| 77 | MP0002693_abnormal_pancreas_physiology | 0.64998905 |
| 78 | MP0003300_gastrointestinal_ulcer | 0.64413302 |
| 79 | MP0005257_abnormal_intraocular_pressure | 0.62136392 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.58376834 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.55324716 |
| 82 | MP0002102_abnormal_ear_morphology | 0.54842377 |
| 83 | MP0003795_abnormal_bone_structure | 0.53833527 |
| 84 | MP0001188_hyperpigmentation | 0.52293758 |
| 85 | MP0008872_abnormal_physiological_respon | 0.52141826 |
| 86 | MP0000920_abnormal_myelination | 0.48939664 |
| 87 | MP0001502_abnormal_circadian_rhythm | 0.48835574 |
| 88 | MP0004742_abnormal_vestibular_system | 0.48806247 |
| 89 | MP0000681_abnormal_thyroid_gland | 0.46607232 |
| 90 | MP0002168_other_aberrant_phenotype | 0.46199449 |
| 91 | MP0005410_abnormal_fertilization | 0.44691303 |
| 92 | MP0005166_decreased_susceptibility_to | 0.42760943 |
| 93 | MP0005174_abnormal_tail_pigmentation | 0.42344082 |
| 94 | MP0001243_abnormal_dermal_layer | 0.39659279 |
| 95 | MP0003172_abnormal_lysosome_physiology | 0.39646758 |
| 96 | MP0002095_abnormal_skin_pigmentation | 0.39490596 |
| 97 | MP0000477_abnormal_intestine_morphology | 0.38562335 |
| 98 | MP0002083_premature_death | 0.37436578 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.37186535 |
| 100 | MP0008569_lethality_at_weaning | 0.34781142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 9.42345304 |
| 2 | T lymphocytopenia (HP:0005403) | 8.96969473 |
| 3 | Abnormality of T cell number (HP:0011839) | 8.83402312 |
| 4 | Autoimmune hemolytic anemia (HP:0001890) | 6.44978185 |
| 5 | Abnormality of T cells (HP:0002843) | 6.02209786 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 5.10132430 |
| 7 | Increased IgM level (HP:0003496) | 4.76709981 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.75223090 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.55331622 |
| 10 | Chronic diarrhea (HP:0002028) | 4.51573220 |
| 11 | IgG deficiency (HP:0004315) | 4.43934573 |
| 12 | Abnormality of eosinophils (HP:0001879) | 4.43426689 |
| 13 | Severe combined immunodeficiency (HP:0004430) | 4.42206470 |
| 14 | Recurrent viral infections (HP:0004429) | 4.39199129 |
| 15 | Eosinophilia (HP:0001880) | 4.38802734 |
| 16 | Granulocytopenia (HP:0001913) | 4.26935031 |
| 17 | Stomatitis (HP:0010280) | 3.89521932 |
| 18 | Joint swelling (HP:0001386) | 3.88237193 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.77844942 |
| 20 | Abnormality of T cell physiology (HP:0011840) | 3.77452644 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.75705891 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.75705891 |
| 23 | IgA deficiency (HP:0002720) | 3.73668571 |
| 24 | Combined immunodeficiency (HP:0005387) | 3.70206665 |
| 25 | Leukocytosis (HP:0001974) | 3.47181284 |
| 26 | IgM deficiency (HP:0002850) | 3.40081677 |
| 27 | Recurrent bronchitis (HP:0002837) | 3.35308183 |
| 28 | Abnormality of B cell number (HP:0010975) | 3.27517237 |
| 29 | Oral leukoplakia (HP:0002745) | 3.16199770 |
| 30 | Myositis (HP:0100614) | 3.14432901 |
| 31 | Thyroiditis (HP:0100646) | 3.13386006 |
| 32 | Menstrual irregularities (HP:0000858) | 3.08848812 |
| 33 | Pustule (HP:0200039) | 3.07116496 |
| 34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.06835717 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.05748593 |
| 36 | Lymphopenia (HP:0001888) | 2.86562945 |
| 37 | Lymphoma (HP:0002665) | 2.80328199 |
| 38 | Glucose intolerance (HP:0000833) | 2.67905038 |
| 39 | Oligomenorrhea (HP:0000876) | 2.60968662 |
| 40 | Renal cortical cysts (HP:0000803) | 2.58249101 |
| 41 | Hypergammaglobulinemia (HP:0010702) | 2.58093858 |
| 42 | Encephalitis (HP:0002383) | 2.53698317 |
| 43 | Vasculitis (HP:0002633) | 2.49638700 |
| 44 | Orchitis (HP:0100796) | 2.49206592 |
| 45 | Meningitis (HP:0001287) | 2.49101846 |
| 46 | Optic neuritis (HP:0100653) | 2.49023575 |
| 47 | Retrobulbar optic neuritis (HP:0100654) | 2.49023575 |
| 48 | Pancytopenia (HP:0001876) | 2.48906803 |
| 49 | Carpal bone hypoplasia (HP:0001498) | 2.46623902 |
| 50 | Recurrent skin infections (HP:0001581) | 2.42799710 |
| 51 | Abnormality of oral frenula (HP:0000190) | 2.38591381 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.35490510 |
| 53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.35464812 |
| 54 | Periodontitis (HP:0000704) | 2.34217348 |
| 55 | Hypoplasia of the thymus (HP:0000778) | 2.27673889 |
| 56 | Hypoproteinemia (HP:0003075) | 2.25979141 |
| 57 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.21960095 |
| 58 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.21960095 |
| 59 | Abnormality of glycolipid metabolism (HP:0010969) | 2.21960095 |
| 60 | Recurrent bacterial skin infections (HP:0005406) | 2.21190885 |
| 61 | B lymphocytopenia (HP:0010976) | 2.16997673 |
| 62 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.13784251 |
| 63 | Increased cerebral lipofuscin (HP:0011813) | 2.13581081 |
| 64 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.12530886 |
| 65 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.11856159 |
| 66 | Recurrent abscess formation (HP:0002722) | 2.10551157 |
| 67 | Agammaglobulinemia (HP:0004432) | 2.03573761 |
| 68 | Obstructive lung disease (HP:0006536) | 2.02672486 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.02672486 |
| 70 | Hypochromic anemia (HP:0001931) | 2.02249697 |
| 71 | Hepatosplenomegaly (HP:0001433) | 2.02012937 |
| 72 | Striae distensae (HP:0001065) | 1.98466328 |
| 73 | Bronchitis (HP:0012387) | 1.98158636 |
| 74 | Premature loss of primary teeth (HP:0006323) | 1.94338424 |
| 75 | Abnormality of the alveolar ridges (HP:0006477) | 1.92892276 |
| 76 | Hemiplegia (HP:0002301) | 1.90984157 |
| 77 | Hemoptysis (HP:0002105) | 1.90955894 |
| 78 | Mediastinal lymphadenopathy (HP:0100721) | 1.88269904 |
| 79 | Vacuolated lymphocytes (HP:0001922) | 1.82670048 |
| 80 | Purpura (HP:0000979) | 1.81941109 |
| 81 | Stomach cancer (HP:0012126) | 1.81063966 |
| 82 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80728794 |
| 83 | Metaphyseal dysplasia (HP:0100255) | 1.80582662 |
| 84 | Abnormality of the prostate (HP:0008775) | 1.79968129 |
| 85 | Acute hepatic failure (HP:0006554) | 1.79887760 |
| 86 | Abnormality of the renal cortex (HP:0011035) | 1.78432516 |
| 87 | Vertebral compression fractures (HP:0002953) | 1.77126797 |
| 88 | Hypoplasia of the uterus (HP:0000013) | 1.75262433 |
| 89 | Hypoalbuminemia (HP:0003073) | 1.72160806 |
| 90 | Abnormal albumin level (HP:0012116) | 1.72160806 |
| 91 | Anorexia (HP:0002039) | 1.70552556 |
| 92 | Nasolacrimal duct obstruction (HP:0000579) | 1.70360882 |
| 93 | Erythema (HP:0010783) | 1.69623460 |
| 94 | Gastrointestinal infarctions (HP:0005244) | 1.65137396 |
| 95 | Eczematoid dermatitis (HP:0000976) | 1.65077397 |
| 96 | Abnormal glucose tolerance (HP:0001952) | 1.64460609 |
| 97 | Pulmonary fibrosis (HP:0002206) | 1.60642877 |
| 98 | Keratoconjunctivitis sicca (HP:0001097) | 1.59558547 |
| 99 | Progressive inability to walk (HP:0002505) | 1.58506222 |
| 100 | Alkalosis (HP:0001948) | 1.58370603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CA | 5.72045116 |
| 2 | TXK | 5.55845989 |
| 3 | KDR | 4.14990679 |
| 4 | ITK | 4.09054277 |
| 5 | MAP4K1 | 3.99600339 |
| 6 | TESK2 | 2.99810681 |
| 7 | FES | 2.68685372 |
| 8 | EIF2AK3 | 2.67061135 |
| 9 | TAOK3 | 2.65434587 |
| 10 | BCKDK | 2.33173060 |
| 11 | CSK | 2.19466688 |
| 12 | JAK3 | 2.08020382 |
| 13 | BUB1 | 1.96567229 |
| 14 | TYK2 | 1.85966158 |
| 15 | IKBKE | 1.85066141 |
| 16 | TYRO3 | 1.65128127 |
| 17 | PRKCQ | 1.63801802 |
| 18 | RIPK4 | 1.54697640 |
| 19 | NUAK1 | 1.52248745 |
| 20 | SYK | 1.48282092 |
| 21 | TNK2 | 1.47825687 |
| 22 | BTK | 1.47250406 |
| 23 | LCK | 1.46557083 |
| 24 | ACVR1B | 1.45484025 |
| 25 | PASK | 1.45345142 |
| 26 | TESK1 | 1.40501621 |
| 27 | MAPKAPK3 | 1.39807507 |
| 28 | LYN | 1.38627601 |
| 29 | FGFR4 | 1.33899683 |
| 30 | KIT | 1.29387017 |
| 31 | PINK1 | 1.23945759 |
| 32 | BLK | 1.20833729 |
| 33 | EIF2AK1 | 1.12770750 |
| 34 | ZAP70 | 1.11878015 |
| 35 | IKBKB | 1.09977683 |
| 36 | PRKD3 | 1.08214032 |
| 37 | MAP2K7 | 1.06416016 |
| 38 | VRK2 | 1.02760069 |
| 39 | TBK1 | 1.02569359 |
| 40 | TEC | 0.96782541 |
| 41 | MAP3K11 | 0.92586252 |
| 42 | ADRBK2 | 0.91285436 |
| 43 | CAMKK1 | 0.90623892 |
| 44 | MAPK11 | 0.90254449 |
| 45 | IRAK4 | 0.88098794 |
| 46 | HCK | 0.84882005 |
| 47 | STK38 | 0.83956514 |
| 48 | MST4 | 0.83729160 |
| 49 | CAMKK2 | 0.81216657 |
| 50 | AKT3 | 0.80691623 |
| 51 | MAP3K14 | 0.80486623 |
| 52 | RET | 0.79556806 |
| 53 | FYN | 0.79379473 |
| 54 | JAK1 | 0.79297974 |
| 55 | ERN1 | 0.78207312 |
| 56 | PIK3CG | 0.78020292 |
| 57 | GRK6 | 0.69439774 |
| 58 | FGFR1 | 0.62694920 |
| 59 | BMPR2 | 0.62687512 |
| 60 | DAPK2 | 0.58991697 |
| 61 | FGFR3 | 0.53948954 |
| 62 | MARK3 | 0.50677766 |
| 63 | DAPK1 | 0.50167024 |
| 64 | PRKCD | 0.48982148 |
| 65 | NEK6 | 0.48614532 |
| 66 | MAP2K6 | 0.45765898 |
| 67 | MAPK12 | 0.45014065 |
| 68 | CSF1R | 0.43870941 |
| 69 | RIPK1 | 0.43603221 |
| 70 | MAP3K12 | 0.43336462 |
| 71 | IGF1R | 0.42788267 |
| 72 | TAOK2 | 0.42699366 |
| 73 | GRK1 | 0.40305555 |
| 74 | MAP4K2 | 0.38178072 |
| 75 | LIMK1 | 0.37498830 |
| 76 | MAP3K7 | 0.34383124 |
| 77 | PAK1 | 0.33627046 |
| 78 | STK10 | 0.32939476 |
| 79 | SRC | 0.32800396 |
| 80 | SIK3 | 0.32306898 |
| 81 | CAMK2D | 0.30878797 |
| 82 | SRPK1 | 0.30787987 |
| 83 | BCR | 0.29346325 |
| 84 | INSR | 0.29253492 |
| 85 | MAPKAPK2 | 0.29184243 |
| 86 | MAP3K3 | 0.28744030 |
| 87 | EGFR | 0.28600837 |
| 88 | ROCK1 | 0.27866619 |
| 89 | PRKCA | 0.25930905 |
| 90 | PRKCB | 0.24647267 |
| 91 | PRKCH | 0.24155201 |
| 92 | PDK1 | 0.23670401 |
| 93 | JAK2 | 0.23218800 |
| 94 | CAMK2A | 0.22556459 |
| 95 | ILK | 0.20966513 |
| 96 | CHUK | 0.20520819 |
| 97 | MAP3K1 | 0.19322946 |
| 98 | PRKD2 | 0.19156127 |
| 99 | VRK1 | 0.19140500 |
| 100 | TAOK1 | 0.17578605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 5.18010568 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.10519745 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 4.34837204 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.11356088 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.74766556 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.51657039 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 3.12683447 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.07776434 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.89193571 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.85085554 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.61076710 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.57935818 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.26540148 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.21460027 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.08980418 |
| 16 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 2.06720389 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 1.90312476 |
| 18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.71134022 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.69024724 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58397706 |
| 21 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.38286468 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.37710696 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35174647 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17920324 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.15426504 |
| 26 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.07559360 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.07443152 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.01625601 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.00766311 |
| 30 | Protein export_Homo sapiens_hsa03060 | 0.96230291 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.95829575 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.95266001 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94789285 |
| 34 | RNA polymerase_Homo sapiens_hsa03020 | 0.85747614 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85299509 |
| 36 | Leishmaniasis_Homo sapiens_hsa05140 | 0.80540912 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79068875 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76453678 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 0.76216637 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74347533 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74152593 |
| 42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71631067 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69935155 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67814787 |
| 45 | Asthma_Homo sapiens_hsa05310 | 0.67577543 |
| 46 | Malaria_Homo sapiens_hsa05144 | 0.66343088 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.64660079 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63729962 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62743280 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60785552 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59267146 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56187905 |
| 53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54718203 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 0.54440096 |
| 55 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54262618 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52276750 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 0.49857547 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.49482543 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46379726 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44847596 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41125738 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40549728 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37564421 |
| 64 | Prion diseases_Homo sapiens_hsa05020 | 0.37201395 |
| 65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35462224 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34731799 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32835562 |
| 68 | Alzheimers disease_Homo sapiens_hsa05010 | 0.32681769 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31693856 |
| 70 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.31274845 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31207915 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.30418747 |
| 73 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.29847941 |
| 74 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.24619249 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22674317 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.21609617 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.21009764 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.19473387 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.16649588 |
| 80 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.13162121 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.10675711 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.09030259 |
| 83 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.08790875 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.06115580 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.06051447 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.05585012 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.05199475 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.04154608 |
| 89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.03681060 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.02812059 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.01810087 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.00499990 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | -0.0541069 |
| 94 | Phototransduction_Homo sapiens_hsa04744 | -0.0450980 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0416367 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | -0.0395671 |
| 97 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0164158 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | -0.0151497 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.0148962 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0082365 |

